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SUMMARY
This manuscript extends our previously published work (based on data from one clinic) on the
association between three drinking water-treatment modalities (boiling, filtering, and bottling)
and diarrhoeal disease in HIV-positive persons by incorporating data from two additional
clinics collected in the following year. We conducted a cross-sectional survey of drinking water
patterns, medication usage, and episodes of diarrhoea among HIV-positive persons attending
clinics associated with the San Francisco Community Consortium. We present combined results
from our previously published work in one clinic (n ¯ 226) with data from these two additional
clinics (n ¯ 458). In this combined analysis we employed logistic regression and marginal
structural modelling of the data. The relative risk of diarrhoea for ‘ always ’ s. ‘ never ’ drinking
boiled water was 0±68 (95 % CI 0±45–1±04) and for ‘ always ’ s. ‘ never ’ drinking bottled water
was 1±22 (95 % CI 0±82–1±82). Drinking filtered water was unrelated to diarrhoea [1±03 (95 % CI
0±78, 1±35) for ‘ always ’ s. ‘ never ’ drinking filtered water]. Adjustment for confounding did not
have any notable effect on the point estimates (0±61, 1±35 and 0±98 for boiled, bottled, and
filtered water respectively, as defined above). The risk of diarrhoea was lower among those
consuming boiled water but this finding was not statistically significant. Because of these
findings, the importance of diarrhoea in immunocompromised individuals, and the limitations
of cross-sectional data further prospective investigations of water consumption and diarrhoea
among HIV-positive individuals are needed.

INTRODUCTION
There is no doubt that widespread outbreaks of
gastrointestinal (GI) infectious illness have occurred
in the United States at times when public watertreatment systems have failed [1, 2]. Recent studies,
* Author for correspondence : 140 Warren Hall, MC 7360, School
of Public Health, University of California, Berkeley, CA 947207360.

however, have begun to question the assumption that
there is little or no risk of GI infectious illness
attributable to the consumption of drinking water
when public water-treatment systems are functioning
properly (i.e. are meeting federal regulatory standards
for pathogen removal and there is no evidence
of an outbreak) [3–6]. Three of these studies
were randomized trials that provided estimates of
diarrhoeal disease attributable to drinking water in
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immunocompetent groups. Recently, attention has
been directed toward specific sub-populations who
may be at increased risk for susceptibility to infection
and severe sequelae after infection. These subpopulations include immunocompromised persons,
children, and the elderly [7]. The goal of this study
was to evaluate the relationship between specific
drinking water-treatment modalities (boiling, filtering
or bottling) and the occurrence of diarrhoea among
HIV-positive persons. We chose to use diarrhoea as
our outcome variable, since the pathogens of interest
that cause the GI illness consist of a heterogeneous
group of viruses, bacteria, and protozoa called waterborne pathogens.
The epidemiology of diarrhoea in immunocompromised populations is very different than that
in general populations. Prior to the introduction of
highly active anti-retroviral therapy (HAART),
chronic diarrhoea affected 50–90 % of the HIVinfected population [8], and was attributed to viral,
bacterial, and parasitic infections. A recent study
suggested that the prevalence of diarrhoea has
dropped since the introduction of HAART but it is
still notable in the HIV-positive population [9]. Some
opportunistic infections (such as cryptosporidiosis)
may be life-threatening to HIV-positive persons but of
limited importance in non-immunocompetent individuals. Additionally, there are non-infectious causes
of diarrhoea in HIV-positive persons. These include
medications that are frequently prescribed for HIVpositive individuals such as the protease inhibitors,
especially nelfinavir. These factors could confound
any study of risk factors for diarrhoea in this
population.
Few studies have evaluated the association between
diarrhoeal disease and drinking water in HIV-positive
individuals. In a cross-sectional serosurvey for
markers of prior Cryptosporidium infection among
HIV-positive men, sexual practice was significantly
associated with infection whereas drinking-water
practices were not [10]. In our original survey of 226
patients in San Francisco we found no statistically
significant association between boiled water use and
diarrhoea in the past 7 days (OR 0±5, 95 % CI 0±2–1±6)
[11]. The small size of this study, however, limited our
ability to firmly estimate the relationship between
water modality and diarrhoea. Additionally, results
from this study suggested that even in the HAART
era, it is likely that diarrhoeal diseases unrelated to
medication use remain a significant cause of morbidity
in HIV-positive individuals.

METHODS
Between October 1998 and April 1999, the first survey
was administered at the San Francisco Veterans
Affairs Medical Center (SFVAMC). The SFVAMC
cohort consisted of 226 patients and its results were
published previously [11].
Between December 1999 and June 2000, the same
survey was administered to 458 additional patients at
two health clinics associated with the Community
Consortium within San Francisco : the Positive Health
Unit at the San Francisco General Hospital and
Clinica Esperanza at the Mission Neighborhood
Health Center. The Community Consortium (CC) is a
community-based clinical research programme that
has established a network of health-care providers
within the San Francisco Bay Area. The study
instrument and protocol were approved by the
Institutional Review Boards from the University of
California at Berkeley, the University of California at
San Francisco, and the Centers for Disease Control
and Prevention.
We used a cross-sectional design because we were
interested in obtaining broad HIV-positive population
prevalence estimates of both GI illness and drinking
water patterns. We administered the survey to patients
from three of the larger HIV clinics in San Francisco
as an efficient way to obtain a large sample size.
The survey addressed specific drinking water
behaviours, medication usage, CD4 count, and other
potential factors associated with GI illness. Specifically, the survey included questions on : (1) drinking
water behaviour ; (2) other risk factors for diarrhoeal
disease such as medication usage, sexual practice,
foods consumed, contact with animals, and travel ; (3)
self-reported symptoms ; (4) demographic information
(age, race, and income) ; and (5) knowledge of and
attitudes about drinking water risks. Boiled, bottled,
and filtered water use were coded as ‘ never ’, ‘ rarely ’,
‘ sometimes ’, ‘ often ’ or ‘ always ’, and were modelled
as dummy variables with ‘ never ’ as the baseline.
Since some of the intermediate categories (‘often ’,
‘ sometimes ’ and ‘ rarely ’) had very low numbers, they
were collapsed into one category (‘sometimes ’).
For the SFVAMC cohort, clinical records of the
most recent CD4 count measure and medication
usage were obtained from a chart review of the
patients. These data were not available from the CC
cohort, and therefore we collected CD4 count and
medication usage data from self-reports. All medications were classified by a pharmacist with respect to
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Table 1. Demographic characteristics
VAMC
(n ¯ 226)

Community
Consortium
(n ¯ 458)

Total
(n ¯ 684)

2 (!1 %)
53 (12 %)
173 (38 %)
178 (39 %)
43 (9 %)
2 (! 1 %)
2 (! 1 %)
1 (! 1 %)
4 (1 %)

2 (!1 %)
60 (9 %)
212 (31 %)
259 (38 %)
104 (15 %)
24 (4 %)
13 (2 %)
1 (!1 %)
9 (1 %)

Age
11–20
21–30
31–40
41–50
51–60
61–70
71–80
"80
Missing

0 (0 %)
7 (3 %)
39 (17 %)
81 (36 %)
61 (27 %)
22 (10 %)
11 (5 %)
0 (0 %)
5 (2 %)

Gender
Male
Female

226 (100 %)
0 (0 %)

325 (71 %)
133 (29 %)

551 (81 %)
133 (19 %)

Years of education
Less than high-school
Some high-school
High-school degree
Post high-school
Missing

5 (2 %)
9 (4 %)
59 (26 %)
153 (68 %)
0

34 (7 %)
119 (26 %)
135 (30 %)
165 (36 %)
5 (1 %)

39 (6 %)
128 (19 %)
194 (28 %)
318 (46 %)
5 (1 %)

Race
Black
White
Hispanic
Native American
Asian
Other
Missing

43 (19 %)
152 (68 %)
19 (8 %)
2 (1 %)
2 (1 %)
7 (3 %)
1 (!1 %)

221 (48 %)
117 (26 %)
90 (20 %)
7 (2 %)
11 (2 %)
9 (2 %)
3 (1 %)

264 (39 %)
269 (39 %)
109 (16 %)
9 (1 %)
13 (2 %)
16 (2 %)
4 (1 %)

Income
!$20 000
$20 000–$30 000
$30 001–$40 000
$40 001–$50 000
$50 001–$100 000
" $100 000
Missing

152 (68 %)
33 (15 %)
15 (7 %)
8 (4 %)
12 (5 %)
3 (1 %)
3 (1 %)

380 (83 %)
38 (8 %)
12 (3 %)
9 (2 %)
1 (! 1 %)
2 (! 1 %)
16 (3 %)

532 (78 %)
71 (10 %)
27 (4 %)
17 (2 %)
13 (2 %)
5 (1 %)
19 (3 %)

Currently employed
Yes
No
Missing

66 (29 %)
152 (67 %)
8 (4 %)

81 (18 %)
371 (81 %)
6 (1 %)

147 (21 %)
523 (76 %)
14 (2 %)

CD4}mm$
0–200
201–358
359–511
"511
Missing

55 (24 %)
51 (23 %)
53 (23 %)
52 (23 %)
15 (7 %)

78 (17 %)
70 (15 %)
71 (16 %)
77 (17 %)
162 (35 %)

Medication risk
None
0±1–0±27
0±28–0±34
0±35–0±42
"0±42

21 (10 %)
54 (24 %)
36 (16 %)
50 (23 %)
60 (27 %)

116 (25 %)
84 (18 %)
35 (8 %)
85 (19 %)
138 (30 %)
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Table 2. Association of risk factors with diarrhoea for the categorical ariables
Estimated
counterfactual
RR (95 % CI)

No. (with
diarrhoea)

No. (without
diarrhoea)

Unadjusted
RR (95 % CI)

Drinking water
Heard of CDC drinking water guidelines ?
Yes
No

50
232

62
299

1±02 (0±81–1±28)
1±0 (reference)

How concerned about drinking water
and its health effects?
Not at all concerned
A little concerned
Very concerned

54
110
98

103
135
99

1±0 (reference)*†
1±31 (1±01–1±69)*
1±45 (1±12–1±87)*

Always or often uses at least one type
of water treatment?
Yes
No

141
142

173
198

1±08 (0±90–1±28)
1±0 (reference)

How often drinks boiled water?
Never
Sometimes
Always

184
77
16

233
90
37

1±0 (reference)
1±05 (0±86–1±27)
0±68 (0±45–1±04)*

1±0 (reference)
0±97 (0±74, 1±26)
0±61 (0±29–1±31)

How often drinks bottled water ?
Never
Sometimes
Always

24
208
47

51
244
73

1±0 (reference)
1±44 (1±02–2±03)*
1±22 (0±82–1±82)

1±0 (reference)
1±33 (0±87, 2±04)
1±35 (0±84, 2±18)

How often drinks filtered water?
Never
Sometimes
Always

172
69
35

233
87
45

1±0 (reference)
1±04 (0±84–1±28)
1±03 (0±78–1±35)

1±0 (reference)
0±98 (0±74, 1±28)
0±98 (0±67, 1±44)

Medications
Number of medications with "10 %
diarrhoeal side effects
0
1
2
3
4
5

105
97
46
22
5
4

181
114
45
16
12
2

1±0 (reference)*†
1±25 (1±01–1±55)*
1±38 (1±07–1±77)*
1±58 (1±16–2±15)*
0±80 (0±38–1±70)
1±82 (1±01–3±26)

Any medications with "10 %
diarrhoeal side effects
Yes
No

174
105

189
181

1±31 (1±08–1±57)*
1±0 (reference)

Taken any medications in the past 6 months
Yes
No

238
41

282
88

1±44 (1±10–1±89)*
1±0 (reference)

Immune status
CD4 " ¯ 500}mm$
CD4 ! 500}mm$

51
175

93
175

0±71 (0±55–0±90)*
1±0 (reference)

88
183

84
269

1±26 (1±05–1±52)*
1±0 (reference)

53
216

44
309

1±33 (1±08–1±64)*
1±0 (reference)

Pets and animal contact
Have any pets at home ?
Yes
No
Clean pet’s urine ?
Yes
No
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Table 2. (cont.)

Any contact with farm animals
Yes
No
Food (eaten in the last 7 days)
Vegetable salad
Yes
No
Red meat
Yes
No
Shellfish
Yes
No
Raw fish
Yes
No

No. (with
diarrhoea)

No. (without
diarrhoea)

Unadjusted
RR (95 % CI)

10
267

4
360

1±68 (1±19–2±36)‡
1±0 (reference)

170
109

211
155

1±08 (0±91–1±30)
1±0 (reference)

70
209

65
300

1±26 (1±04–1±53)*
1±0 (reference)

52
227

61
305

1±08 (0±86–1±35)
1±0 (reference)

10
269

22
344

0±71 (0±42–1±20)
1±0 (reference)

Estimated
counterfactual
RR (95 % CI)

* Significant χ# test of association.
† Significant χ# test for trend.
‡ Significant 2-sided Fisher’s exact test.

their probability of causing diarrhoea. Since each
patient on average took several medications, each
with a different risk of causing diarrhoea due to side
effects, we developed a continuous, composite variable
(‘ medication risk ’) to estimate the overall diarrhoeal
risk associated with a given set of medications [11].
Briefly, the medication risk variable ranged from 0 to
1, where 1 represented the highest risk of causing
diarrhoea. The outcome variable, diarrhoea, was
defined as the presence of two or more loose or
unformed stools on a given day of the week. The
patient answered yes or no to whether they had
experienced diarrhoea in the previous 7 days.
The associations between the risk factors included
in the survey and symptoms of diarrhoea were
assessed using bivariate tabulations and calculations
of relative risks. The relative risk was defined as the
ratio of prevalence estimates between the exposed and
unexposed. To control for potential confounding
factors, we used the Marginal Structural Model
(MSM) approach [12]. Specifically, MSMs require a
model for the distribution of the risk factor given
relevant (to diarrhoea) covariates. Thus we estimated
the probability of being in one of the three levels
of water treatment (‘ never ’, ‘ sometimes ’, ‘ always ’)
given a particular covariate pattern (P(Arcovariates))
using multinomial logistic regression where A ¯
the observed boiling water pattern (‘ always ’,

‘ sometimes ’, ‘ never ’). The inverse of these probabilities was subsequently used as weights in a logistic
regression of diarrhoea status as the outcome variable
and category of water treatment frequency as the
predictor. As explained in Robins et al. [12] this has
the effect of creating a ‘‘ pseudo-population ’’ (known
as counterfactual population) where covariate patterns
are no longer associated with water treatment. One
important assumption with regards to interpreting the
model is that the level of consumption (e.g. ‘ always ’)
is statistically independent of diarrhoea, gien the
coariates. This is essentially the untestable assumption of no unmeasured confounding. The model yields
relative risk estimates comparing counterfactual populations of interest ; e.g. everyone always boils their
drinking water s. no one ever boils their drinking
water. Note, the resulting relative risk has a different
interpretation than the typical results from regression
where we are comparing the conditional probabilities
of disease given a change in the risk factor of interest,
keeping all other covariates (potential confounders)
fixed. To select the appropriate weights for the logistic
regression we used a multinomial logistic regression
model-fitting procedure described by Kooperberg et
al. [13]. As suggested by Robins [12], we report
conservative confidence intervals based on robust or
‘ sandwich ’ estimators of the variance of the coefficient
estimates.
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Table 3. Association of risk factors with diarrhoea for the continuous ariables
n

With diarrhoea
Mean (..)

Without diarrhoea
Mean (..)

Demographic characteristics
Age

646

43±3 (10±1)

43±8 (10±5)

Drinking water
Percent of drinking water treated
Cold glasses of tap water per day at home
Total glasses of tap water per day*

636
633
652

54±0 (34±8)
2±68 (3±4)
7±6 (7±3)

55±9 (35±8)
2±20 (2±91)
6±6 (6±4)

Medications
Probability of diarrhoea from medication*

649

0±34 (0±2)

0±28 (0±2)

Health
CD4*}mm$
CD4*†}mm$

495
490

358 (247)
358 (247)

607 (1760)
440 (310)

* Significant two-sample t-test.
† With 5 outliers removed.

The primary outcome of interest was diarrhoea in
the previous 7 days. Once the weights were estimated,
we used a weighted General Linear Model (GLM)
procedure based on a log link with a binary indicator
of diarrhoea in the previous 7 days as the dependent
variable and indicator variables for water treatment as
the predictor variables. We estimated separate weights
and used separate models for each water treatment
method. The data were entered and organized in
Access97 (Microsoft2), and analysed in S-Plus 4.5
(MathSoft2) and Stata (Version 6.0, Stata Corporation).
RESULTS
The basic demographic composition of the SFVAMC
cohort (n ¯ 226) and the CC cohort (n ¯ 458) are
displayed in Table 1. Although the SFVAMC cohort
was slightly older, totally male, and had fewer blacks
and Hispanics, the two study populations were similar
with respect to immunosuppression (as measured by
CD4 counts).
Data evaluating the univariate association between
several risk factors and the prevalence of diarrhoea
for the combined cohorts are shown in Tables 2 and
3. Although 74 % were concerned and 33 % were very
concerned about drinking water quality, only 18 % of
the cohort had heard about the CDC federal drinking
water guidelines for immunocompromised persons
(http :}}www.cdc.gov}mmwr}PDF}rr}rr5108.pdf ).
Counterfactual relative risk estimates were calculated by the MSM. Covariates considered in model
selection to determine the weights for the MSM

included factors suspected to be associated with
diarrhoea. These factors included : medication use ;
consumption of high-risk foods (shellfish, raw fish,
vegetable salads, uncooked meat) ; race ; CD4 level ;
cleaning up after pets ; presence of pets in the home ;
type of water used (boiled, bottled, filtered, tap) ;
current employment status ; swimming or drinking in
a lake or river ; anal sexual contact ; education ;
household income ; and homelessness. In determining
weights for the MSM, the model selection process
identified variables that were the best predictors of
water treatment. Race and filtering water were the
most important predictors of boiled water use ; age,
boiling water and current employment were predictors
of bottled water use ; and boiling water and presence
of pets in the home were the most important predictors
of filtered water use.
Covariates such as CD4 and medication use, while
highly associated with diarrhoea, did not predict
water treatment method. Since many of the selfreported CD4 measurements were missing (n ¯ 162),
and since CD4 was not an important factor in
determining the weights, we generated weights again,
excluding CD4 from the model, thereby allowing
those 162 individuals with missing CD4 values to be
included in the model. Results were nearly identical to
the model where those with missing CD4 were
excluded.
The associations of ‘ always ’, ‘ sometimes ’, or
‘ never ’ drinking boiled, filtered, or bottled water with
diarrhoea were examined and are presented as both
unadjusted and adjusted relative risk measures (Table
2). The univariate analysis estimated a borderline
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statistically significant association between ‘ always ’
boiling drinking water and diarrhoea 0±68 (0±45–1±04).
The final model for ‘ always ’ compared to ‘ never ’
boiling drinking water did not appreciably change the
point estimate but did widen the confidence intervals
[RR ¯ 0±61 (0±29, 1±31)]. The relative risk point
estimate of ‘ always ’ compared with ‘ never ’ drinking
bottled water was elevated though also not significant.
These point estimates were similar for both the
unadjusted and adjusted estimate, while the CI was
wider in the final model [RR ¯ 1±22 (0±82, 1±82) and
RR ¯ 1±35 (0±84, 2±18) respectively]. Filtered water use
remained unassociated with diarrhoea [RR ¯ 1±03
(0±78–1±35)].
The univariate associations between both medication use and CD4 count and diarrhoea were also
statistically significant. For example the RR of
diarrhoea for those with CD4 "500}mm$ compared
with CD4 !500}mm$ was 0±71 (0±55–0±90), and the
RR of diarrhoea for those taking any medication that
was reported to cause diarrhoea greater than 10 % of
the time compared to those that did not was 1±31
(1±08–1±57). Other significant univariate associations
were contact with animals : RR ¯ 1±26 (1±05–1±52) for
contact with pets ; RR ¯ 1±68 (1±19–2±36) for contact
with farm animals ; and RR ¯ 1±33 (1±08–1±64) for
contact with animal urine.
When the CC and SFVAMC cohorts were analysed
separately, similar relative risks were observed. For
example, ‘ always ’ s. ‘ never ’ drinking boiled water
had a RR of 0±37 (0±1–1±32) for the SFVAMC and 0±73
(0±31–1±7) for the CC. The analogous comparison for
bottled water was RR ¯ 1±16 (0±71–1±87) and 1±71
(1±02–2±89) for the CC and SFVAMC cohorts respectively and for filtered water was RR ¯ 0±72
(0±35–1±48) and 1±16 (0±75–1±81) for the CC and
SFVAMC cohorts respectively.
DISCUSSION
The principal results of this cross-sectional study
suggested that among HIV-positive persons : (1)
boiled water consumption was associated with a
statistically non-significant decreased risk of diarrhoea ; (2) consumption of bottled water was
associated with a statistically non-significant elevated
risk of diarrhoea ; and (3) filtered water consumption
was not associated with diarrhoea. The point estimates
of the association between diarrhoea and boiling
water from the two independent samples, the VAMC
(n ¯ 226), and the CC (n ¯ 458), were strong and
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protective (RR ¯ 0±37 and 0±73, respectively). Analogously, the bottle water risks were elevated in both
groups (RR ¯ 1±16 and 1±71).
It is biologically plausible that boiled water might
be associated with a reduced risk of diarrhoea :
pathogens associated with diarrhoeal disease are, in
general, quite sensitive to temperatures approaching
100 °C, the boiling point of water. Boiling water is,
therefore, generally thought of as the most effective
treatment for infectious pathogens. Nor is it surprising
that filtered water was not associated with diarrhoea
since the efficacy of filters sold to the public varies
from those that only improve taste and aesthetic
qualities to those that effectively filter viruses, bacteria, and protozoa. Although hundreds of millions of
dollars are annually spent on these home watertreatment devices, little is known about the benefits of
such treatment.
The possibility that bottled water may be associated
with an elevated risk of diarrhoea is somewhat
surprising, although the microbiology of bottled water
does indicate the potential for bacterial regrowth. In
Canada, a survey of the microbiology of bottled water
Lalumandier and Ayers [14] demonstrated that 23±3
and 5±5 % exceeded 10# c.f.u.}ml and 10% c.f.u.}ml
respectively for heterotrophic plate count bacteria
(HPC). They compared tap water and bottled water
and found that 6 of 57 samples of bottled water had
bacterial counts "1000 c.f.u.}ml, whereas the tap
water samples never exceeded 2±7 c.f.u.}ml. In an
earlier review of studies in the United Kingdom on the
microbiology and public health of ground waters used
for bottled mineral waters, Hunter [15] concluded that
there was no evidence that consumption of bottled
water provided additional protection as compared to
tap water. Our study highlights the need for additional
studies to clarify the role that bottled water may play
in diarrhoea in immunocompromised individuals.
Although studies linking water consumption to
diarrhoea have been repeatedly conducted in
developing countries, there are relatively few such
studies from developed countries. In a case control
study of diarrhoea, there was no observed relationship
between consumption of tap water and acute diarrhoea in the winter in France [16]. A case control
study of E. coli O157 : H7 presented limited evidence
of a relationship between drinking unchlorinated well
water and infection [17]. In one earlier cross-sectional
study using an HIV-positive cohort, there was no
relationship observed between drinking tap water and
infection with Cryptosporidium [10].
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There are limitations in our study. As is true for any
cross-sectional study, the temporal relationship between the exposure (drinking water) and the outcome
(diarrhoea) is uncertain. It is possible that HIVpositive persons with diarrhoea altered their water
consumption patterns due to the onset of diarrhoea.
Another limitation was our necessary reliance on selfreported symptoms of diarrhoea, which may be
associated with certain biases ; e.g. a participant, for a
variety of reasons, may either mistakenly or intentionally choose not to identify a diarrhoeal episode,
resulting in a misclassification of that disease outcome.
A final limitation in our data is the fact that for the
CC cohort (n ¯ 458), the CD4 count and medication
use was self-reported and only 63 % of these participants provided CD4 count data ; a comparison,
however, of the distribution of 296 self-reported CD4
count data with the 226 CD4 count values obtained
through clinical records for the SFVAMC cohort
suggested that the two distributions were comparable.
This lessens the likelihood that systematic bias was
introduced into the results either by the self-reporting
or by the incomplete reporting. Furthermore, since
our modelling procedure identified no relationship
between CD4 and water treatment after considering
other factors, and since we obtained identical results
even when CD4 level was completely removed from
the model selection process, it is unlikely that
incomplete CD4 reporting could bias the observed
result. There were some differences in the two cohorts
with respect to medication use, gender and racial
composition. Separate analysis of each cohort, however, led to results similar to the analysis of the entire
cohort.
Although not significant at a 95 % confidence level,
the relative risk point estimates suggest the need to
further evaluate whether or not there is a reduced risk
of diarrhoea with the use of boiled water, and an
increased risk of diarrhoea with the use of bottled
water. A more complete understanding of the relationship between drinking water consumption and
diarrhoea is likely to require either prospectively
collected observational data or evidence from randomized trials evaluating drinking water treatment
methods and their impact on rates of diarrhoea.
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